Skip to main content

Table 1 Patients characteristics according to diagnosis and treatment groups

From: Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors

 

Entire group, N = 160 (%)

BS, n = 54 (%)

STS, n = 106 (%)

P-value

SRT, n = 64 (%)

MMT, n = 96 (%)

P-value

Median age, years (range)

55 (19–86)

39 (19–80)

59 (19–86)

< 0.001

66 (28–86)

46 (19–78)

<0.001

Gender

0.09

  

0.94

 Female

74 (46)

30 (56)

44 (41)

 

30 (47)

44 (46)

 

 Male

86 (54)

24 (44)

62 (59)

 

34 (53)

52 (54)

 

Median time since diagnosis, years (range)

6 (0–31)

5 (1–22)

6 (1–31)

0.11

4 (1–19)

6 (1–31)

0.07

Time since diagnosis, years

0.80

  

0.02

 <5

68 (43)

22 (41)

46 (43)

 

34 (53)

34 (35)

 

 ≥5

92 (57)

32 (59)

60 (57)

 

30 (47)

62 (65)

 

Treatment group

< 0.001

   

 SRT

64 (40)

9 (17)

55 (52)

    

 MMT

96 (60)

45 (83)

51 (48)

    
  1. Italic values indicate significance of P-value (P < 0.05)
  2. BS bone sarcoma, STS soft tissue sarcoma, SRT surgery and or radiotherapy group, MMT multimodal treatment group